SEARCH HEALTH CONDITIONS BY ALPHABETS

Hypophosphatasia



Medications for Hypophosphatasia

About Hypophosphatasia:  Hypophosphatasia is a rare hereditary illness that causes elevated levels of alkaline phosphatase enzymes as a result of mutations of tissue nonspecific alkaline phosphatase (TNSALP) gene. Indicators of hypophosphatasia are highly variable and therefore are dependent of their clinical form.

Drugs Used in the Treatment of Hypophosphatasia

This listing of medications have been utilized at the treating this illness, or in some way associated with.

Medication title Rx / OTC Pregnancy CSA AlcoholReviewsRatingPopularity
StrensiqRx N Insert  inspection
0.0

Generic title: asfotase Al-fa systemic

Drug class: mixed metabolic representatives

For users: dose, side effects

For specialists: AHFS DI Monograph, Prescribing Information

asfotase Al-fa Rx N Insert  inspection
0.0

Generic title: asfotase Al-fa systemic

Brand title:  Strensiq

Drug class: mixed metabolic representatives

For users: dosage,

For professionals: az Drug Truth, AHFS DI Monograph

Legend

RxPrescription Only
OTCOn The Counter
Rx/OTCPrescription or Over the Counter
Away Prizes This medication may well not be approved by the FDA for the treatment of the illness.
Pregnancy Category
Asufficient and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters).
BAnimal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
CAnimal reproduction studies have shown an adverse effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
Dthere was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
XStudies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential gains.
NFDA have not classified this drug.
Controlled Substances Act (CSA) Program
Nisn`t subject to the Controlled Substances Act.
1includes a higher potential for abuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision.
2includes a higher potential for abuse. Has a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can cause acute emotional or physical dependence.
3Has a potential for abuse less than those in programs 1 and 2 two. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence.
4includes a minimal potential for abuse in accordance with those in schedule 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5includes a minimal potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence.
Infection
XInteracts with Alcohol.

Browse Treatment Plans

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • Janin
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Further advice

Always consult your healthcare provider to ensure the information displayed on these pages relates to your circumstances.



Top USA Pharma Companies